Enabling the simultaneous detection of mutations in ctDNA and gDNA for research applications on liquid biopsy and FFPE
SIMPLE
Ready-to-use Primers and Probes Mix;
Up to 42 targets in a single reaction
picto-rapide
FAST
DNA-to-result in less than 3 hours
picto-controle
RELIABLE
Target controls included
ACCURATE
Patented technology* included
logo-comptabilite
OPTIMIZED
Universal amplification program for all assays on QIAcuity 5Plex digital PCR system
Cutting-Edge Multiplexed Technology
IDNAPTEX products detect mutations in DNA from plasma (cfDNA) or FFPE tissue (gDNA) for your oncology research.
Our assays are designed with an optimized ready-to-use primers and probes, enabling the simultaneous amplification of multiple targeted mutations in a single well.
Universal Amplification Program compatible for all assays
When combined with the QIAcuity 5Plex digital PCR system, IDNAPTEX delivers results in less than three hours—providing a fast, reliable, and high-performance solution for clinical oncology research.
Accurate detection of mutations
Optimized for ease of use and result reproducibility, the reagents include a Target Process Control (TPC) for enhanced accuracy.
The patented using ID-ICE reagent enables optimal monitoring of the entire pre-analytical process, reinforcing the reliability of the results obtained.